Novartis is leading a group of companies that are considering buying US pharma The Medicines Company searching for a deal that could expand its pipeline of cardiac medicines, according to p
The Medicines Company (TMC) has bet the proverbial farm on cholesterol-lowering candidate inclisiran and is celebrating new safety data that raises the chances of approval when pivotal tria
